127 related articles for article (PubMed ID: 35863671)
21. Stereotactic Radiosurgery for Differentiated Thyroid Cancer Brain Metastases: An International, Multicenter Study.
Bunevicius A; Fribance S; Pikis S; Lee JYK; Buch LY; Moran M; Yang AI; Bernstein K; Mathieu D; Perron R; Liscak R; Simonova G; Patel S; Trifiletti DM; Martínez Álvarez R; Martínez Moreno N; Lee CC; Yang HC; Strickland BA; Zada G; Chang EL; Kondziolka D; Sheehan J
Thyroid; 2021 Aug; 31(8):1244-1252. PubMed ID: 33978475
[No Abstract] [Full Text] [Related]
22. Defining the optimal planning target volume in image-guided stereotactic radiosurgery of brain metastases: results of a randomized trial.
Kirkpatrick JP; Wang Z; Sampson JH; McSherry F; Herndon JE; Allen KJ; Duffy E; Hoang JK; Chang Z; Yoo DS; Kelsey CR; Yin FF
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):100-8. PubMed ID: 25442342
[TBL] [Abstract][Full Text] [Related]
23. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
24. Dose-response relationships for radiotherapy of brain metastases: role of intermediate-dose stereotactic radiosurgery plus whole-brain radiotherapy.
Nieder C; Nestle U; Walter K; Niewald M; Schnabel K
Am J Clin Oncol; 2000 Dec; 23(6):584-8. PubMed ID: 11202802
[TBL] [Abstract][Full Text] [Related]
25. Tumor Control Probability Modeling and Systematic Review of the Literature of Stereotactic Body Radiation Therapy for Prostate Cancer.
Royce TJ; Mavroidis P; Wang K; Falchook AD; Sheets NC; Fuller DB; Collins SP; El Naqa I; Song DY; Ding GX; Nahum AE; Jackson A; Grimm J; Yorke E; Chen RC
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):227-236. PubMed ID: 32900561
[TBL] [Abstract][Full Text] [Related]
26. Initial clinical experience with frameless radiosurgery for patients with intracranial metastases.
Kamath R; Ryken TC; Meeks SL; Pennington EC; Ritchie J; Buatti JM
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1467-72. PubMed ID: 15817352
[TBL] [Abstract][Full Text] [Related]
27. A unified multi-activation (UMA) model of cell survival curves over the entire dose range for calculating equivalent doses in stereotactic body radiation therapy (SBRT), high dose rate brachytherapy (HDRB), and stereotactic radiosurgery (SRS).
Li S; Miyamoto C; Wang B; Giaddui T; Micaily B; Hollander A; Weiss SE; Weaver M
Med Phys; 2021 Apr; 48(4):2038-2049. PubMed ID: 33590493
[TBL] [Abstract][Full Text] [Related]
28. Stereotactic ablative radiation therapy for brain metastases with volumetric modulated arc therapy and flattening filter free delivery: feasibility and early clinical results.
Fiorentino A; Giaj-Levra N; Tebano U; Mazzola R; Ricchetti F; Fersino S; Di Paola G; Aiello D; Ruggieri R; Alongi F
Radiol Med; 2017 Sep; 122(9):676-682. PubMed ID: 28447313
[TBL] [Abstract][Full Text] [Related]
29. Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.
Liang X; Penagaricano J; Zheng D; Morrill S; Zhang X; Corry P; Griffin RJ; Han EY; Hardee M; Ratanatharathom V
Radiat Oncol; 2016 Jan; 11():10. PubMed ID: 26800883
[TBL] [Abstract][Full Text] [Related]
30. The Incidence and Its Associated Factors Relevant to Brain Radionecrosis That Requires Intervention Following Single or Fractionated Stereotactic Radiosurgery Using Vero4DRT for Brain Metastases.
Yamada T; Ohtakara K; Kamomae T; Itoh J; Shimada H; Ishihara S; Naganawa S
Cureus; 2022 Jun; 14(6):e25888. PubMed ID: 35844334
[TBL] [Abstract][Full Text] [Related]
31. Changing practice patterns of Gamma Knife versus linear accelerator-based stereotactic radiosurgery for brain metastases in the US.
Park HS; Wang EH; Rutter CE; Corso CD; Chiang VL; Yu JB
J Neurosurg; 2016 Apr; 124(4):1018-24. PubMed ID: 26473783
[TBL] [Abstract][Full Text] [Related]
32. Heuristic knowledge-based planning for single-isocenter stereotactic radiosurgery to multiple brain metastases.
Ziemer BP; Sanghvi P; Hattangadi-Gluth J; Moore KL
Med Phys; 2017 Oct; 44(10):5001-5009. PubMed ID: 28731267
[TBL] [Abstract][Full Text] [Related]
33. Linac-based VMAT radiosurgery for multiple brain lesions: comparison between a conventional multi-isocenter approach and a new dedicated mono-isocenter technique.
Ruggieri R; Naccarato S; Mazzola R; Ricchetti F; Corradini S; Fiorentino A; Alongi F
Radiat Oncol; 2018 Mar; 13(1):38. PubMed ID: 29506539
[TBL] [Abstract][Full Text] [Related]
34. Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: results and toxicity.
Ernst-Stecken A; Ganslandt O; Lambrecht U; Sauer R; Grabenbauer G
Radiother Oncol; 2006 Oct; 81(1):18-24. PubMed ID: 16978720
[TBL] [Abstract][Full Text] [Related]
35. The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery.
Yamada Y; Katsoulakis E; Laufer I; Lovelock M; Barzilai O; McLaughlin LA; Zhang Z; Schmitt AM; Higginson DS; Lis E; Zelefsky MJ; Mechalakos J; Bilsky MH
Neurosurg Focus; 2017 Jan; 42(1):E6. PubMed ID: 28041329
[TBL] [Abstract][Full Text] [Related]
36. The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases.
Varlotto JM; Flickinger JC; Niranjan A; Bhatnagar A; Kondziolka D; Lunsford LD
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1125-32. PubMed ID: 15990018
[TBL] [Abstract][Full Text] [Related]
37. Stereotactic laser ablation as treatment for brain metastases that recur after stereotactic radiosurgery: a multiinstitutional experience.
Ali MA; Carroll KT; Rennert RC; Hamelin T; Chang L; Lemkuil BP; Sharma M; Barnholtz-Sloan JS; Myers C; Barnett GH; Smith K; Mohammadi AM; Sloan AE; Chen CC
Neurosurg Focus; 2016 Oct; 41(4):E11. PubMed ID: 27690654
[TBL] [Abstract][Full Text] [Related]
38. Stereotactic radiosurgery for newly diagnosed brain metastases: comparison of three dose levels.
Rades D; Hornung D; Blanck O; Martens K; Khoa MT; Trang NT; Hüppe M; Terheyden P; Gliemroth J; Schild SE
Strahlenther Onkol; 2014 Sep; 190(9):786-91. PubMed ID: 24663288
[TBL] [Abstract][Full Text] [Related]
39. Hypofractionated stereotactic radiotherapy for brain metastases from lung cancer : Evaluation of indications and predictors of local control.
Ishihara T; Yamada K; Harada A; Isogai K; Tonosaki Y; Demizu Y; Miyawaki D; Yoshida K; Ejima Y; Sasaki R
Strahlenther Onkol; 2016 Jun; 192(6):386-93. PubMed ID: 27169391
[TBL] [Abstract][Full Text] [Related]
40. Single-Isocenter Volumetric Modulated Arc Therapy vs. CyberKnife M6 for the Stereotactic Radiosurgery of Multiple Brain Metastases.
El Shafie RA; Tonndorf-Martini E; Schmitt D; Celik A; Weber D; Lang K; König L; Höne S; Forster T; von Nettelbladt B; Adeberg S; Debus J; Rieken S; Bernhardt D
Front Oncol; 2020; 10():568. PubMed ID: 32457829
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
